Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria

American Journal of Gastroenterology

Volumn 106, Issue 7, 2011, Pages 1299-1307

  Hellström, Per M ^a   Saito, Yuri A ^b   Bytzer, Peter ^c   Tack, Jan ^d   Mueller Lissner, Stefan ^e   Chang, Lin ^f  

^a UPPSALA UNIVERSITY   (Sweden)

^b MAYO CLINIC   (United States)

^c KØGE HOSPITAL   (Denmark)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e Park Klinik Weissensee   (Germany)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; BELLADONNA ALKALOID; CHOLINERGIC RECEPTOR BLOCKING AGENT; LAXATIVE; OPIATE; PARACETAMOL; SPASMOLYTIC AGENT;

ABDOMINAL PAIN; ADULT; ANALGESIA; ARTICLE; BELGIUM; CLINICAL TRIAL; CONSTIPATION; DAILY LIFE ACTIVITY; DEFECATION; DENMARK; DIARRHEA; FEMALE; GERMANY; HUMAN; IRRITABLE COLON; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWEDEN; UNITED STATES;

ABDOMINAL PAIN; ACTIVITIES OF DAILY LIVING; ADULT; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; BELGIUM; CHI-SQUARE DISTRIBUTION; CONSTIPATION; DEFECATION; DENMARK; DIARRHEA; FEMALE; GERMANY; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PAIN MEASUREMENT; PARASYMPATHOLYTICS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SWEDEN; TIME FACTORS; UNITED STATES;

EID: 79960061457     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.78     Document Type: Article

References (28)

1. Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
2. Kellow JE, Gill RC, Wingate DL. Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome. Gastroenterology 1990; 98: 1208-18. (Pubitemid 20143104)
3. Camilleri M, McKinzie S, Busciglio I et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008; 6: 772-81.
4. Olden KW. Approach to the patient with severe, refractory irritable bowel syndrome. Curr Treat Options Gastroenterol 2003; 6: 311-7.
5. Drossman DA, Chang L, Schneck S et al. A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity. Dig Dis Sci 2009; 54: 1532-41.
6. Lembo A, Ameen VZ, Drossman DA. Irritable bowel syndrome: toward an understanding of severity. Clin Gastroenterol Hepatol 2005; 3: 717-25. (Pubitemid 41116722)
7. Spiegel B, Strickland A, Naliboff BD et al. Predictors of patient-assessed illness severity in irritable bowel syndrome. Am J Gastroenterol 2008; 103: 2536-43.
8. Spiegel BM, Gralnek IM, Bolus R et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med 2004; 164: 1773-80. (Pubitemid 39215647)
9. Trentacosti A, Burke L, Griebel D et al. Evolution of clinical trials for irritable bowel syndrome: issues in endpoints and study design. Am J Gastroenterol 2010; 105: 731-5.
10. Turk DC, Dworkin RH, Allen RR et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003; 106: 337-45. (Pubitemid 37505881)
11. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23: 129-38.
12. Pare P, Gray J, Lam S et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin Ther 2006; 28: 1726-35; discussion 1710-1711. (Pubitemid 44841981)
13. Drossman DA, Morris CB, Schneck S et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol 2009; 43: 541-50.
14. Si JM, Wang LJ, Chen SJ et al. Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol 2004; 10: 1059-64.
15. Chassany O, Bonaz B, Bruley Des Varannes S et al. Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/ trimethylphloroglucinol. A randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 2007; 25: 1115-23. (Pubitemid 46587693)
16. Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients ' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998; 10: 415-21. (Pubitemid 28241429)
17. Broderick JE, Schwartz JE, Vikingstad G et al. The accuracy of pain and fatigue items across different reporting periods. Pain 2008; 139: 146-57.
18. Stone AA, Schwartz JE, Broderick JE et al. Variability of momentary pain predicts recall of weekly pain: a consequence of the peak (or salience) memory heuristic. Pers Soc Psychol Bull 2005; 31: 1340-6. (Pubitemid 41422569)
19. Bond B, Quinlan J, Dukes G et al. Irritable bowel syndrome: more than abdominal pain and bowel habit abnormalities. Clin Gastroenterol Hepatol 2009; 7: 73-9.
20. Gralnek I, Hays R, Kilbourne A et al. The impact of IBS on health-related quality of life. Gastroenterology 2000; 119: 654-60.
21. Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18: 671-82. (Pubitemid 37271832)
22. Maxion-Bergemann S, Thielecke F, Abel F et al. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006; 24: 21-37. (Pubitemid 43197228)
23. Talley NJ, Dennis EH, Schettler-Duncan VA et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003; 98: 2454-9. (Pubitemid 37448756)
24. Schmulson M, Lee OY, Chang L et al. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 1999; 94: 2929-35. (Pubitemid 29482760)
25. Tillisch K, Labus JS, Naliboff BD et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005; 100: 896-904. (Pubitemid 40592385)
26. Riedl A, Maass J, Fliege H et al. Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome. J Psychosom Res 2009; 67: 449-55.
27. Faresjo A, Grodzinsky E, Johansson S e t al. Self-reported use of pharmaceuticals among patients with irritable bowel syndrome in primary care. J Manag Care Pharm 2008; 14: 870-7.
28. Stone AA, Shiff man S, Schwartz JE et al. Patientnon-compliance with paper diaries. BMJ 2002; 324: 1193-4.